Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: justification

Regulatory Expectations for Bulk Product Hold Time Justification

Posted on November 26, 2025November 25, 2025 By digi

Regulatory Expectations for Bulk Product Hold Time Justification Comprehensive Guide to Bulk Product Hold Time Justification: Regulatory Expectations and Approval Hold time studies for bulk product represent a critical component in pharmaceutical manufacturing, impacting product quality, regulatory compliance, and operational efficiency. This step-by-step tutorial provides pharmaceutical manufacturing, QA, QC, validation, and regulatory affairs professionals in…

Read More “Regulatory Expectations for Bulk Product Hold Time Justification” »

Hold Time Studies

How to Justify and Document Reprocessing in Batch Records

Posted on November 25, 2025November 25, 2025 By digi

How to Justify and Document Reprocessing in Batch Records Step-by-Step Guide to Justifying and Documenting Reprocessing in Batch Records In pharmaceutical manufacturing, rework and reprocessing of batches GMP form a critical part of maintaining product quality and regulatory compliance. When a batch deviates from expected quality parameters or manufacturing conditions, reprocessing may be considered to…

Read More “How to Justify and Document Reprocessing in Batch Records” »

Rework & Reprocessing

How to Justify Clean Hold Times in Validation Reports

Posted on November 25, 2025November 24, 2025 By digi

How to Justify Clean Hold Times in Validation Reports Step-by-Step Guide to Justifying Clean Hold Times in Validation Reports In pharmaceutical manufacturing, establishing and documenting appropriate clean hold times for cleaned equipment is critical to maintaining product quality and compliance. A well-executed hold time study for cleaned equipment provides the basis for defining time limits…

Read More “How to Justify Clean Hold Times in Validation Reports” »

Clean Hold Time

How to Justify Cleaning Limits in Validation Protocols and Reports

Posted on November 25, 2025November 24, 2025 By digi

How to Justify Cleaning Limits in Validation Protocols and Reports Step-by-Step Guide to Justify Cleaning Limits in Validation Protocols and Reports Establishing scientifically and regulatorily sound cleaning limits is a critical part of pharmaceutical manufacturing, ensuring product safety and compliance with Good Manufacturing Practice (GMP) standards. The calculation of cleaning validation limits must be backed…

Read More “How to Justify Cleaning Limits in Validation Protocols and Reports” »

Limits & Calculations

How to Justify Cleaning Agent Selection in Validation Protocols

Posted on November 25, 2025November 24, 2025 By digi

How to Justify Cleaning Agent Selection in Validation Protocols Step-by-Step Guide to Justifying Cleaning Agent Selection for Pharma Equipment In pharmaceutical manufacturing, the choice of cleaning agents for equipment is a critical decision that impacts product quality, patient safety, and regulatory compliance. Selecting the appropriate cleaning agents and properly documenting their justification within validation protocols…

Read More “How to Justify Cleaning Agent Selection in Validation Protocols” »

Cleaning Agents

Regulatory Expectations for Bulk Product Hold Time Justification

Posted on November 24, 2025November 24, 2025 By digi

Regulatory Expectations for Bulk Product Hold Time Justification Step-by-Step Guide to Regulatory Expectations for Bulk Product Hold Time Justification Within pharmaceutical manufacturing, the justification and control of bulk product hold times constitute a critical element of Good Manufacturing Practice (GMP). Regulatory authorities across the US, UK, and EU impose stringent requirements to ensure the integrity,…

Read More “Regulatory Expectations for Bulk Product Hold Time Justification” »

Hold time studies for bulk product

How to Set and Justify Theoretical and Actual Yields to Regulators

Posted on November 24, 2025November 24, 2025 By digi

How to Set and Justify Theoretical and Actual Yields to Regulators Step-by-Step Guide to Setting and Justifying Theoretical and Actual Yields According to GMP In pharmaceutical manufacturing, establishing and documenting theoretical and actual yield limits is a critical component of yield reconciliation GMP guidelines. These yield limits serve as essential quality metrics during batch production,…

Read More “How to Set and Justify Theoretical and Actual Yields to Regulators” »

Yield & Reconciliation

FDA Data Integrity Inspections: How to Defend Your Controls and Rationale

Posted on November 15, 2025November 14, 2025 By digi

FDA Data Integrity Inspections: How to Defend Your Controls and Rationale Practical Guide to Meeting FDA Data Integrity Expectations During Inspections Data integrity remains a cornerstone of regulatory compliance within pharmaceutical manufacturing. The FDA data integrity expectations are rigorous and enforcing, particularly when it comes to data integrity and compliance with drug CGMP. Navigating FDA…

Read More “FDA Data Integrity Inspections: How to Defend Your Controls and Rationale” »

FDA Data Integrity Guidance & Expectations

Don’t Adjust Sampling Volumes Without Documented GMP Justification

Posted on July 12, 2025November 14, 2025 By digi

Don’t Adjust Sampling Volumes Without Documented GMP Justification Do Not Change Sampling Volumes Without GMP-Approved Justification Remember: Sampling volumes must follow validated procedures—any deviation must be documented, justified, and approved under GMP compliance rules. Why This Matters in GMP Sampling plays a critical role in determining the quality of raw materials, in-process products, and finished…

Read More “Don’t Adjust Sampling Volumes Without Documented GMP Justification” »

GMP Tips

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme